Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultrahypofractionated Stereotactic Body Radiotherapy
Background: Survival outcomes after primary radiotherapy for localized prostate cancer (PCa) are excellent, regardless of the specific treatment modality. For this reason, health-related quality of life (HRQOL) has come to play an ever more important role in treatment selection. Stereotactic body ra...
Main Authors: | Piotr Milecki, Anna Adamska, Anna Rucinska, Grzegorz Pałucki, Agnieszka Szumiło, Agnieszka Skrobała, Agata Jodda, Michał Michalak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/2/233 |
Similar Items
-
Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?
by: Borowicz Dorota Maria, et al.
Published: (2022-03-01) -
Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
by: Hun Jung Kim, et al.
Published: (2015-12-01) -
Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
by: Jeong Hoon Phak, et al.
Published: (2016-03-01) -
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
by: Jorgo Kliton, et al.
Published: (2021-07-01) -
The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High Risk Localized Prostate Cancer
by: Yu-Wei eLin, et al.
Published: (2014-10-01)